跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HEPCLUDEX bulevirtide (as acetate) 2 mg powder for injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
HEPCLUDEX bulevirtide (as acetate) 2 mg powder for injection vial
Approved
STANDARD
HEPCLUDEX bulevirtide (as acetate) 2 mg powder for injection vial
Gilead Sciences Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
d7fee1c5b9f3b3b3
Company
Gilead Sciences Pty Ltd
Type
Standard
Approval Details
Approval Id
d7fee1c5b9f3b3b3
Product Name
HEPCLUDEX bulevirtide (as acetate) 2 mg powder for injection vial
Artg Id
407179
Artg Name
HEPCLUDEX bulevirtide (as acetate) 2 mg powder for injection vial
Sponsor
Gilead Sciences Pty Ltd
Company Detail Path
/organization/gilead-sciences-pty-limited
Artg Date
2024-07-30
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/209d867b84927fadffee084b6020de99.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/c44141fe3ef440aed1bf2f016d73e60e.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
d7fee1c5b9f3b3b3
Type
Standard
Back to TGA Approvals
